Ikarian Capital, LLC Rezolute, Inc. Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
A detailed history of Ikarian Capital, LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 887,230 shares of RZLT stock, worth $4.69 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
887,230
Previous 903,744
1.83%
Holding current value
$4.69 Million
Previous $3.89 Million
10.73%
% of portfolio
0.75%
Previous 1.57%
Shares
2 transactions
Others Institutions Holding RZLT
# of Institutions
62Shares Held
38.5MCall Options Held
1.6KPut Options Held
24.6K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$59.7 Million0.13% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$14.8 Million1.99% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.58MShares$13.6 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$10.2 Million0.0% of portfolio
-
Blackstone Inc New York, NY1.74MShares$9.23 Million0.04% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $205M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...